Breadcrumb Home / Investors & Media / Investors & Media / Press releases Press releases Explore Investors & Media Explore Investors & Media Investor Overview Press Releases Archived Press Releases Events & Presentations Corporate Governance Committee Composition Management Team Board of Directors Financials & Filings SEC Filings Stock Information Historical Stock Lookup Investment Calculator Analyst Coverage Investor FAQs Contact IR or Media Year None20242023202220212020201920182017 April 6, 2021 Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Read This Press Release March 22, 2021 Scholar Rock Announces Publication of Preclinical Pharmacology, Pharmacokinetics, and Safety Profile of SRK-181 in the International Journal of Toxicology Read This Press Release March 18, 2021 Scholar Rock Announces the Addition of Joshua Reed to Its Board of Directors Read This Press Release March 17, 2021 Scholar Rock Announces Issuance of U.S. Patent Protecting Add-On or Combination Therapy with a Myostatin Inhibitor for the Treatment of Spinal Muscular Atrophy Read This Press Release March 15, 2021 Scholar Rock Presents TOPAZ Interim Analysis Data for Apitegromab in Spinal Muscular Atrophy at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference Read This Press Release March 9, 2021 Scholar Rock Reports Full Year 2020 Financial Results and Highlights Business Progress Read This Press Release February 4, 2021 Scholar Rock Announces Senior Management Promotions Read This Press Release January 27, 2021 Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit Read This Press Release Pagination First page « first Previous page ‹ previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page next › Last page last » RSS Feeds Search
Year None20242023202220212020201920182017 April 6, 2021 Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Read This Press Release March 22, 2021 Scholar Rock Announces Publication of Preclinical Pharmacology, Pharmacokinetics, and Safety Profile of SRK-181 in the International Journal of Toxicology Read This Press Release March 18, 2021 Scholar Rock Announces the Addition of Joshua Reed to Its Board of Directors Read This Press Release March 17, 2021 Scholar Rock Announces Issuance of U.S. Patent Protecting Add-On or Combination Therapy with a Myostatin Inhibitor for the Treatment of Spinal Muscular Atrophy Read This Press Release March 15, 2021 Scholar Rock Presents TOPAZ Interim Analysis Data for Apitegromab in Spinal Muscular Atrophy at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference Read This Press Release March 9, 2021 Scholar Rock Reports Full Year 2020 Financial Results and Highlights Business Progress Read This Press Release February 4, 2021 Scholar Rock Announces Senior Management Promotions Read This Press Release January 27, 2021 Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit Read This Press Release Pagination First page « first Previous page ‹ previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page next › Last page last »